EMD-29209

Single-particle
3.18 Å
EMD-29209
3D View Gallery
Deposition: 16/12/2022
Map released: 01/02/2023
Last modified: 13/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-29209
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 8fis summary report (pdf.gz) Map and 8fis FULL report (pdf.gz)
EMICSS annotations (xml)

Structure of Bispecific CAP256V2LS-J3 Fab in complex with BG505 DS-SOSIP.664

EMD-29209

Single-particle
3.18 Å
EMD-29209
3D View Gallery
Deposition: 16/12/2022
Map released: 01/02/2023
Last modified: 13/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Human immunodeficiency virus 1, Lama glama, Homo sapiens
Sample: CAP256V2LS-J3-3 Fab in complex with BG505 DS-SOSIP.664
Fitted models: 8fis

Deposition Authors: Gorman J , Kwong PD
Bispecific antibody CAP256.J3LS targets V2-apex and CD4-binding sites with high breadth and potency.
Zhang B, Gorman J , Kwon YD, Pegu A , Chao CW, Liu T, Asokan M, Bender MF , Bylund T , Damron L , Gollapudi D, Lei P, Li Y, Liu C, Louder MK, McKee K, Olia AS, Rawi R, Schon A, Wang S , Yang ES, Yang Y, Carlton K, Doria-Rose NA, Shapiro L, Seaman MS, Mascola JR, Kwong PD
(2023) MABs , 15 , 2165390 - 2165390
PUBMED: 36729903
DOI: doi:10.1080/19420862.2023.2165390
ISSN: 1942-0870